Rethinking Thyroid Cancer Treatment: Knowing When Less Is More

Recent advancements have certainly improved thyroid cancer outcomes, but are all treatments and surgeries essential? Jason Hunt, MD, the clinical director of neck and throat surgical oncology at Huntsman Cancer Institute and University of Utah Health, breaks down the risks of overdiagnosis and overtreatment. Learn the pivotal questions to ask your doctor and understand when the contemporary "wait and see" strategy might be your best path forward.

Episode metadata supplied by the publisher feed · Published Oct 4, 2023

Embed this episode

Attribution link and audio player

What this episode covers

Navigate thyroid cancer treatments with an informed lens. Learn about the risks of overdiagnosis and overtreatment, key questions for your doctor, and when a 'wait and see' approach may be ideal.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Rethinking Thyroid Cancer Treatment: Knowing When Less Is More

0:00 5:45

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Scope?

This episode is 5 minutes long.

When was this The Scope episode published?

This episode was published on October 4, 2023.

Can I download this The Scope episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!